Biotronik Inc.

6024 Jean Road

Lake Oswego

97035-5369

USA

800-547-0394

800-291-0470

[email protected]

http://www.biotronikusa.com

Product Categories

Remote Monitoring, Pacemakers, Cardiac Resynchronization Therapy Devices (CRT), Leads Implantable Devices

Related Content

First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold

News | Stents Bioresorbable

BIOMAG-I Study OCT Analysis Confirmed That BIOTRONIK’s Newest Resorbable Magnesium Scaffold Resorbed at 12 Months

September 5, 2023 — New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process following ...

September 05, 2023

Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023

News | Cardiovascular Clinical Studies

12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT

August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ...

August 30, 2023

Biotronik Announces the Full Market Release of Its Newest Family of Pacemaker and CRT-P Devices, With Patient-Centric Technologies for Better Patient Care and Workflow Simplification

News | Pacemakers

First Implant of Amvia Sky in Europe, the World’s First Pacemaker Approved for LBBAP

August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in ...

August 21, 2023

A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention

News | Artificial Intelligence

AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

July 18, 2023

No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB

News | Drug-Eluting Balloons

BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

July 14, 2023

A subgroup analysis of the HOST-IDEA randomized controlled trial showed efficacy differences of Ultrathin Strut DES

News | Stents Drug Eluting

Late-Breaking Study Data: BIOTRONIK’s Orsiro DES Outperforms Other Ultrathin Strut Drug-Eluting Stent

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

July 12, 2023

The Amvia Edge pacemaker platform introduces always-on, automatic MR detection algorithm to fully streamline MRI workflow

News | Pacemakers

BIOTRONIK Receives FDA Approval For Next-Generation Family of Pacemakers

July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...

July 06, 2023

Rapid adoption of wireless cardiac monitoring devices and continuous advancements in remote monitoring technology are generating significant business opportunities for companies in the cardiovascular diagnostic and monitoring devices market

Feature | Implantable Cardiac Monitor (ICM)

Cardiovascular Diagnostic and Monitoring Devices Market to Cross $29B by 2031

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...

June 13, 2023

The Amvia family enables physiological pacing and workflow optimization to help physicians deliver exceptional patient-centric care with less effort.

News | Pacemakers

Biotronic Receives CE Approval for the World’s First Pacemaker and CRT-P Family Approved for Left Bundle Branch Pacing

May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...

May 12, 2023

Six-month results from the BIOMAG-I clinical study including intravascular imaging data were presented at CRT 2023

News | Stents Bioresorbable

New Data Highlight Promising Angiographic and Safety Profile of BIOTRONIK’s Third Generation Resorbable Magnesium Scaffold

March 16, 2023 — Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the latest results of the ...

March 16, 2023